Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 2
2003 1
2004 2
2005 1
2006 3
2007 4
2008 4
2009 2
2010 3
2011 7
2012 5
2013 9
2014 8
2015 6
2016 7
2017 13
2018 4
2019 10
2020 6
2021 10
2022 10
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group. Tacconelli E, et al. Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21. Lancet Infect Dis. 2018. PMID: 29276051
Update on the epidemiology of carbapenemases in Latin America and the Caribbean.
García-Betancur JC, Appel TM, Esparza G, Gales AC, Levy-Hara G, Cornistein W, Vega S, Nuñez D, Cuellar L, Bavestrello L, Castañeda-Méndez PF, Villalobos-Vindas JM, Villegas MV. García-Betancur JC, et al. Among authors: villegas mv. Expert Rev Anti Infect Ther. 2021 Feb;19(2):197-213. doi: 10.1080/14787210.2020.1813023. Epub 2020 Sep 11. Expert Rev Anti Infect Ther. 2021. PMID: 32813566 Review.
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.
Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, Herc E, Alenazi T, Kaye KS, Garcia-Diaz J, Li L, Kanj SS, Liu Z, Oñate JM, Salata RA, Marimuthu K, Gao H, Zong Z, Valderrama-Beltrán SL, Yu Y, Tambyah P, Weston G, Salcedo S, Abbo LM, Xie Q, Ordoñez K, Wang M, Stryjewski ME, Munita JM, Paterson DL, Evans S, Hill C, Baum K, Bonomo RA, Kreiswirth BN, Villegas MV, Patel R, Arias CA, Chambers HF, Fowler VG Jr, Doi Y, van Duin D, Satlin MJ; Antibacterial Resistance Leadership Group and Multi-Drug Resistant Organism Network Investigators. Reyes J, et al. Among authors: villegas mv. Lancet Microbe. 2023 Mar;4(3):e159-e170. doi: 10.1016/S2666-5247(22)00329-9. Epub 2023 Feb 9. Lancet Microbe. 2023. PMID: 36774938 Free PMC article.
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.
Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. Munoz-Price LS, et al. Among authors: villegas mv. Lancet Infect Dis. 2013 Sep;13(9):785-96. doi: 10.1016/S1473-3099(13)70190-7. Lancet Infect Dis. 2013. PMID: 23969216 Free PMC article. Review.
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Wang M, Earley M, Chen L, Hanson BM, Yu Y, Liu Z, Salcedo S, Cober E, Li L, Kanj SS, Gao H, Munita JM, Ordoñez K, Weston G, Satlin MJ, Valderrama-Beltrán SL, Marimuthu K, Stryjewski ME, Komarow L, Luterbach C, Marshall SH, Rudin SD, Manca C, Paterson DL, Reyes J, Villegas MV, Evans S, Hill C, Arias R, Baum K, Fries BC, Doi Y, Patel R, Kreiswirth BN, Bonomo RA, Chambers HF, Fowler VG Jr, Arias CA, van Duin D; Multi-Drug Resistant Organism Network Investigators. Wang M, et al. Among authors: villegas mv. Lancet Infect Dis. 2022 Mar;22(3):401-412. doi: 10.1016/S1473-3099(21)00399-6. Epub 2021 Nov 9. Lancet Infect Dis. 2022. PMID: 34767753 Free PMC article.
Microbiological and Clinical Aspects of Raoultella spp.
Appel TM, Quijano-Martínez N, De La Cadena E, Mojica MF, Villegas MV. Appel TM, et al. Among authors: villegas mv. Front Public Health. 2021 Aug 2;9:686789. doi: 10.3389/fpubh.2021.686789. eCollection 2021. Front Public Health. 2021. PMID: 34409007 Free PMC article. Review.
Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals.
Mojica MF, De La Cadena E, García-Betancur JC, Porras J, Novoa-Caicedo I, Páez-Zamora L, Pallares C, Appel TM, Radice MA, Castañeda-Méndez P, Gales AC, Munita JM, Villegas MV. Mojica MF, et al. Among authors: villegas mv. mSphere. 2023 Apr 20;8(2):e0065122. doi: 10.1128/msphere.00651-22. Epub 2023 Mar 6. mSphere. 2023. PMID: 36877058 Free PMC article.
The epidemiology of carbapenemases in Latin America and the Caribbean.
Escandón-Vargas K, Reyes S, Gutiérrez S, Villegas MV. Escandón-Vargas K, et al. Among authors: villegas mv. Expert Rev Anti Infect Ther. 2017 Mar;15(3):277-297. doi: 10.1080/14787210.2017.1268918. Epub 2016 Dec 20. Expert Rev Anti Infect Ther. 2017. PMID: 27915487 Review.
116 results